IkappaBalpha promoter polymorphisms in patients with Behçet's disease

Area of Science:

• Immunogenetics
• Rheumatology
• Molecular Biology

Background:

• Behçet's disease is a rare multisystem inflammatory disorder of unknown etiology.
• Genetic factors, particularly those influencing immune regulation, are implicated in Behçet's disease pathogenesis.
• The IkappaBalpha gene plays a crucial role in the nuclear factor-kappaB (NF-κB) signaling pathway, which is involved in inflammation.

Purpose of the Study:

• To investigate the association between specific IkappaBalpha promoter polymorphisms and Behçet's disease.
• To determine if these polymorphisms influence the clinical manifestations of Behçet's disease, such as skin lesions.

Main Methods:

• Genotyping of five IkappaBalpha promoter polymorphisms (-881A/G, -826C/T, -550A/T, -519C/T, -297C/T) in 86 Behçet's disease patients and 120 healthy controls.
• Polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) was used for genotyping.
• Haplotype analysis was performed to assess combinations of polymorphisms.

Main Results:

• Significant differences in genotype frequencies of IkappaBalpha -826C/T and -826T/T were observed between Behçet's disease patients and controls.
• The IkappaBalpha -826T allele frequency was significantly increased in patients.
• Specific haplotypes (e.g., -881A -826T -550A -519C -297C) were more frequent in patients, while another (-881A -826C -550A -519C -297C) was decreased.
• The IkappaBalpha -826T/T genotype was associated with a higher prevalence of skin lesions.

Conclusions:

• The IkappaBalpha -826T allele and certain haplotypes may contribute to susceptibility to Behçet's disease.
• The IkappaBalpha -826T/T genotype is linked to the development of skin lesions in Behçet's disease.
• These findings highlight the role of IkappaBalpha gene variations in Behçet's disease pathogenesis.